Carlyle Group Inc.

Position in ACET — Adicet Bio, Inc.

CIK 1527166 WASHINGTON, DC

Position in ACET

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,592,308

+$337,260 QoQ

Shares Held

184,295

0.0% QoQ

Ownership

1.97%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#11

of 56 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Carlyle Group Inc. holds $44,066,764 across 6 Biotechnology names. ACET ranks #3 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PHAT	Phathom Pharmaceuticals, Inc.	3,496,808	$37,940,366
2	SPRB	Spruce Biosciences, Inc.	38,620	$2,085,480
3	ACET	Adicet Bio, Inc. This page	184,295	$1,592,308
4	OKUR	OnKure Therapeutics, Inc.	269,895	$1,230,721
5	QTTB	Q32 Bio Inc.	60,363	$769,024
6	JSPR	Jasper Therapeutics, Inc.	1,066,189	$448,865

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,592,308	184,295	0.0%	Shares	Defined	2026-08-07
2026-03-31	$1,255,048	184,295	0.0%	Shares	Defined	2026-05-08
2025-12-31	$1,551,763	184,295	-93.7%	Shares	Defined	2026-02-13
2025-09-30	$2,388,461	2,948,718	0.0%	Shares	Defined	2025-11-07
2025-06-30	$1,798,717	2,948,718	0.0%	Shares	Defined	2025-08-08
2025-03-31	$2,226,282	2,948,718	0.0%	Shares	Defined	2025-05-09
2024-12-31	$2,836,666	2,948,718	0.0%	Shares	Defined	2025-02-13
2024-09-30	$4,246,153	2,948,718	0.0%	Shares	Defined	2024-11-08
2024-06-30	$3,567,948	2,948,718	0.0%	Shares	Defined	2024-08-09
2024-03-31	$6,929,487	2,948,718	+39.4%	Shares	Defined	2024-05-03
2023-12-31	$3,998,077	2,115,385	0.0%	Shares	Defined	2024-02-02
2023-09-30	$2,898,077	2,115,385	0.0%	Shares	Defined	2023-11-03
2023-06-30	$5,140,385	2,115,385	0.0%	Shares	Defined	2023-08-04
2023-03-31	$12,184,617	2,115,385	—	Shares	Defined	2023-05-05
No filing history on record for this holder in this stock.